<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01342900</url>
  </required_header>
  <id_info>
    <org_study_id>IOTO-001</org_study_id>
    <nct_id>NCT01342900</nct_id>
  </id_info>
  <brief_title>Intraoperative Optimisation of Tissue Oxygenation</brief_title>
  <official_title>Intraoperative Monitoring and Optimisation of Tissue Oxygenation In High-Risk Surgical Patients for Reduction of Postoperative Complications: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Groningen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Monitoring and optimizing tissue oxygenation (StO2) in high-risk surgery and/or high-risk
      surgical patients may decrease the risk of postoperative complications.

      Tissue hypoxia occurs frequently during high-risk surgery in high-risk patients. The
      investigators want to see if an algorithm aimed at optimizing intraoperative tissue
      oxygenation reduces perioperative complications as well as length of stay in the intensive
      care unit (ICU LOS), 28-day mortality, and the duration of mechanical ventilation in these
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of perioperative complications</measure>
    <time_frame>during operation</time_frame>
    <description>organ dysfunction, SOFA score, troponin T, creatinin, CRP</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Higk Risk Surgery</condition>
  <arm_group>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The data from the InSPectra Monitor in the Control group will be inaccessible for the Investigator since this is not a part of their daily medical practice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment group,</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The data given by the monitor will be available for the Investigator and used to apply the optimization protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>connected to the InSpectra Monitor</intervention_name>
    <arm_group_label>Treatment group,</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        . Major elective surgery

          -  Aged over 65 years with moderate functional limitation of one or more organ systems

          -  ASA classification III or IV, i.e. severe cardiac, vascular, respiratory or metabolic
             illness resulting in severe functional limitation

          -  Routine use of arterial and central venous lines

          -  Planned postoperative stay on ICU or PACU

        Exclusion Criteria:

          -  Refusal of consent

          -  acute myocardial ischemia prior to enrolment

          -  patients receiving palliative treatment only

          -  disseminated malignancy

          -  patients unlikely to survive more than 6 hours

          -  emergency surgery

          -  transplantations

          -  neurosurgical patients

          -  patients undergoing extensive liver surgery requiring low CVP management
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas W.L. Scheeren, Prof.dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2011</study_first_submitted>
  <study_first_submitted_qc>April 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2011</study_first_posted>
  <last_update_submitted>February 20, 2013</last_update_submitted>
  <last_update_submitted_qc>February 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Groningen</investigator_affiliation>
    <investigator_full_name>Prof.dr.T.W.L.Scheeren</investigator_full_name>
    <investigator_title>Prof.dr.</investigator_title>
  </responsible_party>
  <keyword>tissue oxygenation</keyword>
  <keyword>higk risk surgery</keyword>
  <keyword>high risk patient</keyword>
  <keyword>postoperative complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

